Home / Team
The people
Built cell therapies before. Now building the data.
Leaders from Sana, Resilience, Pfizer and Fate, supported by advisors and consultants in manufacturing, commercialization and translational science.
We started by crafting cells for cures. Now we turn what they show us into human cell intelligence.
Leadership
Rajib Biswas, PhDCEO · Co-founderCardiac cell therapy leadership at Sana; technical evaluation at Resilience. UW and Stanford GSB.
Aitor Aguirre, PhDScientific Co-FounderInventor of MSU’s human heart-organoid platform, recognized by NHLBI.
Frank Teoh, MSVP Engineering · Co-founder20+ years in ML and large-scale data. Nine patents.
Richard J. Anderson, PhDVP Technical OperationsOxxon employee #5; Pfizer and NantKwest; built MSAT at Fate Therapeutics.
Anand Giddabasappa, PhDAdvisor, Translational Pharmacology15+ years in translational pharmacology.
Matthieu Bauer, PhDAssoc. Director, Process Dev13 years in hESC/hiPSC cardiomyocyte differentiation.
Nagasoujanya Annasamudram, PhDTeam Lead, CytoHub.AIML engineer in biomedical imaging and single-cell sequencing.
Satish Kumar, PhDAI/ML Lead EngineerLeads applied AI/ML engineering.
Advisors
Rahul Singhvi, ScDAdvisor, commercialization strategyFormer CEO of Resilience and Novavax.
Randy Berholtz, JDStrategic AdvisorLife science entrepreneur and lawyer; 25+ years as CEO of two private biotechs.
Chris NowersAdvisor, strategic partnershipsFormer ONK CEO and head of Kite Europe.
Mohammad El-Kalay, PhDAdvisor, CMC & scalable manufacturingCell-therapy process development and GMP manufacturing.
Vish Krishnan, PhDAdvisorJacobs Family Chair in Management and Engineering Leadership; Faculty Director at Rady and CIID.
R&D & Engineering
Rista WhiteResearch Associate IUCLA graduate in stem cell biology and science communication.
Madhoolika CCytoHub.AI InternSupports data analysis and model development.
Hriddhy HazraCytoHub.AI InternSupports data analysis and model development.
Consultants
Brynley LeeExecutive Consultant, Corp. Dev. & CommercializationSix-time CEO, most recently at Basilard BioTech.
Matthew J. PeloConsultant, Finance (Fractional CFO)Financial strategy, planning and operations.
Oscar Abilez, MD, PhDPrincipal ConsultantStanford-trained cardiovascular tissue engineer.
Najah Abi-Gerges, PhDPrincipal Consultant22+ years in cardiac drug discovery.
Erez Perry, PhDSenior Consultant, Cell-based AssayCell-based assay development and validation strategy.